Diabetic peripheral neuropathy (DPN) is one of the most common forms of neuropathic pain and occurs in up to 30% of patients with diabetes. Despite the prevalence of this condition, DPN is often underreported, underrecognized, and undertreated. This activity uses a case-based approach to introduce strategies that primary care clinicians can use in daily practice to improve the recognition and management of DPN.
A patient waiting room tool has been developed to promote a discussion between a patient with diabetes and his or her healthcare provider on the importance of foot care and the occurrence of DPN in patients with diabetes. The PDF for this tool can found under the display window for each of the two patient cases in this activity.
Upon completion of this activity, participants should be able to:
In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:
Louis Kuritzky, MD, has disclosed the following relevant financial relationships:
Consultant: Boehringer-Ingelheim, Lilly, Novo Nordisk, Sanofi-Aventis
Aaron I. Vinik, MD, PhD, FCP, MACP, has disclosed the following relevant financial relationships:
Consultant: Merck, Novartis Pharmaceuticals, Pfizer, R.W. Johnson Pharmaceutical Research Institute, Sanofi-Aventis
Curatio CME Institute
Thomas Finnegan, PhD, Associate Medical Director, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.
Penn State College of Medicine
Robert Gabbay, MD, PhD, has disclosed the following relevant financial relationships:
Speakers Bureau: Merck
Penn State staff involved in the development and review of this activity have disclosed no relevant financial relationships.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Penn State College of Medicine, and Pfizer do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Penn State College of Medicine, or Pfizer. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Policy on Privacy and Confidentiality
Curatio CME Institute collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest. The information is not shared or used for commercial purposes unless prior permission has been granted by the user.
Curatio CME Institute may collect standard Web traffic data such as time and date of visit. Curatio CME Institute uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio CME Institute does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio CME Institute does, when required, provide the minimum subset of information to third parties that are responsible for accreditation of and issuance of certification for CME/CE tests. By participating in the Web-based activity, the user agrees that Curatio CME Institute has full permission to provide this minimum subset of information to the third parties as required by law.
This activity has been designed to meet the educational needs of primary care clinicians, nurse practitioners, physician assistants, and other health care providers involved in the diagnosis and management of patients suspected with DPN.
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the intended audience.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and Curatio CME Institute. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period April 16, 2012 to April 16, 2013, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the posttest and activity evaluation form, including the certificate information section.
To obtain a certificate, participants must receive a score of 70% or better on the posttest. The posttest can be accessed at the end of the activity. Please e-mail any questions to firstname.lastname@example.org.